With the analysis among 16,021 patents, we discovered top 446 key players by total patent application. Aragon Pharmaceuticals, Inc., Merck & Co., Inc., Agensys, Inc. are dominant in this area. They take 5.69% of the total patent filing.
Aragon Pharmaceuticals, Inc.
California, United States
Patent: 340
New Jersey, United States
Patent: 301
California, United States
Patent: 271
Indiana, United States
Patent: 247
F. Hoffmann-La Roche Ltd.
Antwerpen, Belgium
Patent: 222
Tennessee, United States
Patent: 192
Basel-Stadt, Switzerland
Patent: 182
OncoTherapy Science, Inc.
Kanagawa-ken, Japan
Patent: 182
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 173
With the analysis among 262 patents, we discovered top 43 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Biosplice Therapeutics, Inc., Asana BioSciences LLC are active in this area.
Institut National de la Santé et de la Recherche Médicale
Biosplice Therapeutics, Inc.
California, United States
Patent: 19
New Jersey, United States
Patent: 17
Aspen Park Pharmaceuticals, Inc.
New York, United States
Patent: 16
Saskatchewan, Canada
Patent: 13
Minnesota, United States
Patent: 11
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 10
WindMIL Therapeutics, Inc.
New Jersey, United States
Patent: 9
With the analysis among related 3,649 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Janssen Pharmaceutica NV, Aragon Pharmaceuticals, Inc., Regents of the University of California take 6.58% of patent filing during this period.
Antwerpen, Belgium
Patent: 85
Aragon Pharmaceuticals, Inc.
California, United States
Patent: 84
Regents of the University of California
California, United States
Patent: 71
The Johns Hopkins University
University of Tennessee Research Foundation
Tennessee, United States
Patent: 45
Hinova Pharmaceuticals, Inc.
Sichuan Sheng, China
Patent: 44
Abbisko Therapeutics Co., Ltd.
Shanghai Shi, China
Patent: 37
Gyeonggi-do, South Korea
Patent: 37
Dizal Pharmaceutical Co., Ltd
Jiangsu Sheng, China
Patent: 35
With the analysis among related 3,649 patents in last 5 years, we discover 207 new entrants. FutureChem Co., Ltd., Dizal Pharmaceutical Co., Ltd, ESSA Pharma, Inc. are the most active new entrants in this area.
Gyeonggi-do, South Korea
Patent: 37
Dizal Pharmaceutical Co., Ltd
Jiangsu Sheng, China
Patent: 35
British Columbia, Canada
Patent: 33
Institut régional du Cancer de Montpellier
Propella Therapeutics, Inc.
North Carolina, United States
Patent: 16
Heidelberg Pharma Research GmbH
Sunshine Lake Pharma Co. Ltd.
Guangdong Sheng, China
Patent: 15
Advanced Accelerator Applications (Italy) SRL
Progenics Pharmaceuticals, Inc.
New York, United States
Patent: 12
With the analysis among 6,607 patents, we discovered top 258 universities and scientific research institutions by total patent application. University of British Columbia, The Johns Hopkins University, Baylor College of Medicine are dominant in this area. They take 16.72% of the total patent filing.
University of British Columbia
British Columbia, Canada
Patent: 284
The Johns Hopkins University
Baylor College of Medicine
Texas, United States
Patent: 84
Ruprecht-Karls-Universität Heidelberg
Baden-Württemberg, Germany
Patent: 75
New York, United States
Patent: 67
University of Southern California
California, United States
Patent: 65
Georgetown University School of Medicine
District of Columbia, United States
Patent: 59
Washington, United States
Patent: 52
Eastern Virginia Medical School
Virginia, United States
Patent: 52
Thomas Jefferson University
Pennsylvania, United States
Patent: 51